US to Drop Most COVID-19 Vaccine Mandates Next Week
The Biden Administration will lift most federal COVID-19 vaccine mandates next week, as the pandemic public health emergency ends on May 11.
The Biden Administration will lift most federal COVID-19 vaccine mandates next week, as the pandemic public health emergency ends on May 11.
Patients with solid tumors do not appear to have an increased risk of side effects from COVID-19 vaccination, according to a systematic review.
Several factors influenced the likelihood of COVID-19 vaccination among patients with cancer who already had COVID-19, a new study suggests.
The FDA has authorized use of the bivalent Pfizer-BioNTech COVID-19 vaccine as a booster dose for children 6 months through 4 years of age.
The mean time to resolution of axillary lymphadenopathy after a COVID-19 vaccine booster is 102 days, according to a study.
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
In patients with hematologic malignancies, uptake of COVID-19 vaccines is high for the first 2 doses but declines with each subsequent dose, a study suggests.
Vaccination with Moderna’s COVID-19 vaccines will remain free for US adults even after the COVID-19 public health emergency ends on May 11.
Pfizer-BioNTech’s bivalent COVID-19 vaccine may not protect cancer patients from the most common omicron subvariant in circulation now, a study suggests.
COVID-19 vaccines did not reduce the risk of severe COVID-19 among cancer patients who received radiation, CAR T-cell therapy, or HSCT.